Abstract:Abstract INTRODUCTION Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of the gastrointestinal tract. Data are limited regarding how longevity in IBD compares to the general population. The aim of this study was to compare the mean age of death and causes of mortality between patients with IBD and the general population in a nationally representative cohort. METHODS A retrospective study using 2010-2019 data from the National Readmissions Database (NRD) was performed. We identified hospitalized patients with CD and UC using International Classification of Diseases (ICD) codes. We compared the mean age of death and most common causes of mortality in CD, UC, and non-IBD patients. RESULTS The mean age of in-hospital death was significantly lower in the CD group (64.60 years) compared to the UC and non-IBD groups (67.43 and 67.07 years, respectively, p<0.01). Among all age groups, the highest death rates were among those ages 71 through 80 years of age (p<0.01). The UC group had significantly higher rates of death associated with cardiovascular causes, including myocardial infarction, congestive heart failure and cardiovascular disease, and infectious causes, including Clostridioides difficile infection and sepsis. Death rates did not significantly differ among the groups for those with diagnoses of leukemia and lymphoma (p=0.20 and p=0.19, respectively). UC patients had the highest in-hospital rate of death per year from 2010-2019, followed by the CD and non-IBD groups. Common diagnoses associated with death across all ages in the CD, UC, and non-IBD groups included fluid/electrolyte imbalance, respiratory failure, anoxic brain injury, sepsis, and renal failure. CONCLUSION While those with UC had higher in-hospital death dates, those with CD were more likely to die younger compared to the general population. UC patients were more likely to die if diagnosed with cardiovascular disorders or infections. Investigation of factors that drive premature mortality in CD patients and higher rates of mortality in UC patients is crucial to guide practice improvements and for management of co-morbid conditions. Table 1 Patient demographics and hospital characteristics. Figure 1 Death rates comparing non-IBD, CD and UC groups with specific inpatient diagnoses. * p < 0.05.

What problem does this paper attempt to address?

The paper attempts to address the issue of predicting future trends in the prevalence of inflammatory bowel disease (IBD) and analyzing its impact on the healthcare system. Specifically, the researchers constructed a partial differential equation (PDE) model to simulate changes in IBD incidence under different scenarios, thereby predicting the prevalence of IBD. Additionally, the study explores the mortality rates and main causes of death among IBD patients across different age groups, as well as the impact of non-alcoholic fatty liver disease (NAFLD) on clinical outcomes and mortality risk in IBD patients. ### Main Issues: 1. **Predicting Future Trends in IBD**: - Researchers predicted changes in IBD prevalence from 2020 to 2043 using a model that considered different incidence scenarios (annual increases of 2%, 1%, stable, decreases of 1%, 2%). - The goal is to understand the trend in IBD prevalence, particularly how the growth rate of prevalence will gradually slow down as incidence rates stabilize. 2. **Analyzing Mortality Rates and Causes in IBD Patients**: - Comparing the average age of death and main causes of death between Crohn's disease (CD) and ulcerative colitis (UC) patients with the general population. - Exploring differences in mortality rates across different age groups, particularly the high mortality rate between ages 71 to 80. 3. **Studying the Impact of NAFLD on IBD Patients**: - Analyzing the in-hospital mortality rate, clinical outcomes, and resource utilization of CD and UC patients with NAFLD. - Assessing whether NAFLD increases the risk of death and adverse clinical outcomes in IBD patients. ### Research Background: - IBD is a chronic inflammatory disease affecting the digestive tract, including Crohn's disease and ulcerative colitis. - Understanding the trends in IBD prevalence and patient characteristics is crucial for the rational allocation of healthcare resources and clinical management. - Non-alcoholic fatty liver disease (NAFLD) is an emerging condition that may negatively impact the clinical outcomes of IBD patients. ### Research Methods: - **Trend Prediction**: Using a partial differential equation (PDE) model to simulate changes in IBD incidence under different scenarios and predict future prevalence. - **Mortality Analysis**: A retrospective study using data from the National Readmissions Database (NRD) from 2010-2019 to compare in-hospital mortality rates and main causes of death among CD, UC, and non-IBD patients. - **NAFLD Impact Study**: Querying data from the National Inpatient Sample (NIS) from 2017-2020 to analyze clinical outcomes and resource utilization in CD and UC patients with NAFLD. ### Research Conclusions: - **Trend Prediction**: The model predicts that the prevalence of IBD will gradually increase, but the growth rate will slow down, especially as incidence rates stabilize. - **Mortality Analysis**: The average in-hospital death age for CD patients is significantly lower than for UC and non-IBD patients, with UC patients having higher mortality rates due to cardiovascular diseases and infections. - **NAFLD Impact**: CD and UC patients with NAFLD exhibit higher in-hospital mortality rates and adverse clinical outcomes, including higher risks of cardiogenic shock, cardiac arrest, and gastrointestinal bleeding. These findings help healthcare managers better prepare to meet the future needs of IBD patients, particularly elderly patients and those with NAFLD.

MORTALITY IN INFLAMMATORY BOWEL DISEASE: A LONGITUDINAL POPULATION-BASED STUDY IN THE UNITED STATES

Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020

Associations Between Inflammatory Bowel Disease, Social Isolation, and Mortality: Evidence from a Longitudinal Cohort Study

P675 Associations Between Inflammatory Bowel Disease, Social Isolation, and Mortality: Evidence from UK Biobank Cohort Study

P1174 The disease course of elderly patients with Inflammatory Bowel Disease two years prior to their death

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis

Interstitial Lung Disease as an emerging contributor to mortality in patients with Inflammatory Bowel Disease: A population-based epidemiological study

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.

S991 Increasing Mortality of Inflammatory Bowel Disease in Women: A Population-Based Time-Trend Analysis Using the Global Burden of Diseases Database, 1990-2019

All-cause mortality of hospitalized inflammatory bowel disease patients: a multicenter study from Iran

HOSPITAL READMISSION AND MORTALITY RATES IN PATIENTS WITH CONCURRENT DEPRESSION AND INFLAMMATORY BOWEL DISEASE: INSIGHTS FROM THE NATIONAL READMISSIONS DATABASE, 2016–2019

RISING INCIDENCE, MORTALITY, AND DISABILITY-ADJUSTED LIFE YEARS OF INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES: A SYSTEMIC ANALYSIS OF THE GLOBAL BURDEN OF DISEASE STUDY

Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

TRENDS OF INFLAMMATORY BOWEL DISEASE BURDEN IN THE UNITED STATES (1990-2019), PROJECTIONS OF DEATHS TO 2040: INSIGHTS FROM THE 2019 GLOBAL BURDEN OF DISEASE STUDY

Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study

The association between inflammatory bowel disease and all-cause and cause-specific mortality in the UK Biobank

P1133 Relative survival and cause-specific mortality of a Chilean Inflammatory Bowel Disease cohort

Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study among Half a Million Adults in UK Biobank

Clinical Presentation and Outcome of Critically Ill Patients with Inflammatory Bowel Disease

S1063 Inflammatory Bowel Disease Mortality: A Cross-Sectional Analysis of Rural and Urban Disparities 1999-2020